The Food and Drug Law Institute annual conference will be held on December 12-13, 2012 in Washington, DC. The two- day conference welcomes attorneys, litigators, regulators, compliance experts, consultants, and academics in the drug, medical devices, biologics, food...
FierceBiotech has compiled a list of the 20 top pharma-academic collaborations from 2012 which can be found here. This list notes the Big Pharma players who have collaborated with universities and academic medical centers and gone above and beyond typical research...
Our Board will still meet the holiday week of 4th of July. Please submit all documents and forms by end of day July 3rd for review in the July 12, 2012 regularly scheduled meeting. To discuss your upcoming study review needs, contact us at 317.899.9341 or email...
Pearl Pathways’ co-founder and COO, Gretchen Miller Bowker, will be leading a discussion presented by ASQ Biomedical Division covering the similarities and differences between INDs and IDEs and everything in between. The discussion will be held at the...
A group of bipartisan senators introduced a plan to streamline the FDA’s regulation that would speed up the process of taking innovations to the market and encourage innovation. The bill would also focus on restoring balance to the conflict of interest...
Today, we announced some very exciting news. Pearl IRB has grown. To meet the needs of our clients, we have expanded our service offerings. Pearl Pathways, the new parent company, will be organized into three distinct and efficient business units. Pearl IRB remains...
